Find an expert
Our panel of editors are available for interview
Shanti Raman
Editor-in-Chief of BMJ Paediatrics Open
Shanti Raman is a Consultant Paediatrician, with sub-specialty training in Community Child Health, epidemiology and public health. She is the Director of Community Paediatrics – South Western
Sydney, where she is responsible for clinical services in Child Development and Child Protection across the region, providing academic leadership and directing research and training. Her research
and teaching interests include health of migrants and refugees, indigenous child health, child rights and child maltreatment, quality and safety in health, global maternal, newborn and child health.
Professor Gisli Jenkins
Chair of the Editorial Board for BMJ Open Respiratory Research
Professor Gisli Jenkins is an NIHR Research Professor and holds the Margaret Turner-Warwick Chair of Thoracic Medicine at Imperial College London, Head of the Margaret Turner-Warwick Centre for Fibrosing Lung Diseases at the National Heart and Lung Institute. Prof Jenkins’ research focuses on Interstitial Lung Diseases, and Pulmonary Fibrosis in particular. He is the Principal Investigator of a number of longitudinal observational studies including the PROFILE study, the INJUSTIS Study, the UKILD Post COVID ILD study as well as the DEMISTIFI Multi-Morbidity consortium.
Professor Ronald F. van Vollenhoven
Editor-in-Chief of Lupus Science & Medicine
Professor Ronald F. van Vollenhoven is a distinguished rheumatologist and immunologist, known for his significant contributions in the field. He currently holds the position of Chair of the Department of Rheumatology and Clinical Immunology at Amsterdam UMC and directs the Amsterdam Rheumatology Centre. With a background in immunology and extensive training in Internal Medicine and Rheumatology, he has dedicated his career to the development and evaluation of biological and immunomodulatory treatments for rheumatic diseases. Dr. Van Vollenhoven has played a pivotal role in establishing crucial registries, including the Stockholm registry for biological therapies (STURE database), and has been a principal investigator in numerous clinical trials.
Professor Caroline Finch AO
Editor-in-Chief of Injury Prevention
Professor Caroline Finch AO is the Deputy Vice-Chancellor (Research), Edith Cowan University. She is one of Australia’s leading injury epidemiologists, particularly known internationally for her public-health-focused injury prevention research. Her influential research has informed the development of injury surveillance and data systems, the implementation and evaluation of preventive measures, and the dissemination of safety advice and guidance. Her research outcomes have directly informed safety policy for Government Departments of Sport and Health, health promotion/injury prevention agencies, and sports bodies worldwide. In 2015, she was awarded the International Distinguished Career Award from the American Public Health Association’s Injury Control and Emergency Health Services Section. In 2018, she became an Officer of the Order of Australia for ‘distinguished service to sports medicine’.
Dr Ellen Weber
Editor-in-Chief of Emergency Medicine Journal
Dr Ellen Weber is an emergency medicine physician in San Francisco, California. She received her medical degree from Harvard Medical School and has been in practice for more than 20 years. She has worked clinically in community, county and academic emergency departments, and conducts research in topics related to health policy. She is currently a Professor of Emergency Medicine and Vice Chair at UCSF.
Professor Ganesan Karthikeyan
Editor-in-Chief Open Heart
Professor Karthikeyan is a clinical, interventional cardiologist and a Senior International Fellow of the Population Health Research Institute at McMaster University in Canada, as well as Professor of Cardiology at AIIMS. His research is mainly focused on cardiovascular diseases affecting low and middle income countries, including valvular heart disease, particularly rheumatic heart disease (RHD), mechanical valve thrombosis, anticoagulation, and indigenous drug-eluting stents.
